Johnson & Johnson’s DARZALEX SC gets positive CHMP opinion

Janssen-Cilag International NV, a Johnson & Johnson company (NYSE:JNJ) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), recommended DARZALEX for multiple myeloma treatment.

Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products